Navigation Links
Researchers Identify New Genes Linked to the Origins of Alzheimer’s, Says Cure Alzheimer's Fund
Date:6/24/2013

Boston (PRWEB) June 24, 2013

Research uncovering 12, new gene variations connected to the cause of the early-onset familial form of Alzheimer’s disease (EO-FAD), which generally strikes before the age of 65, is being published in the journal Molecular Psychiatry.

The Cure Alzheimer’s Fund-supported research conducted a comprehensive genome-wide screen of over 100 EO-FAD families, identifying copy number variations (CNVs) in early onset families where the three genes and their mutations known to cause EO-FAD were not found. CNVs consist of abnormal deletions, duplications, or rearrangements of large sections of human genome DNA, and are known to make a significant contribution to genetic variation.

“Every new gene or gene mutation found related to Alzheimer’s pathology provides new targets for intervention in the pathology — new ways to stop the disease,” said the project’s lead researcher Dr. Rudolph Tanzi of Massachusetts General Hospital, Harvard Medical School and Chair of the Cure Alzheimer’s Fund’s Research Consortium. “Part of the reason why so many Alzheimer’s drugs have failed is that we in the research field have not understood enough about the origins of the disease to develop interventions that are both safe and effective. By learning more about the very complex genetic underpinnings of the disease — what genes affect risk or protection for the disease, and what functions they perform, and how they contribute to the pathology — we have a much better chance to stop the disease quicker.”

Prior to Tanzi’s latest research, only one CNV had been linked to Alzheimer’s disease through his research and co-discovery completed in the 1980’s and 90’s of mutations in three genes — amyloid precursor protein (APP), presenilin 1 and 2 (PSEN1 and PSEN2) that cause roughly 50 percent of EO-FAD.

Lead author, Raj Hooli, an Instructor in Neurology at MGH and Harvard, said “These are the first EO-FAD gene mutations to be described since the presenilin genes in 1995. Our hope is to use these as we did the original EO-FAD genes to accelerate novel therapies that can prevent and treat Alzheimer’s disease.”

About Cure Alzheimer’s Fund

The Cure Alzheimer’s Fund is governed by a board of directors; administered by a small, full-time staff; and guided scientifically by a Research Consortium and Scientific Advisory Board, which includes a Nobel Laureate. Cure Alzheimer's Fund™ is a 501(c)(3) public charity. Cure Alzheimer’s Fund has supported 77 projects in 45 laboratories of leading Alzheimer’s researchers in the United States and abroad.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10847001.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... PA (PRWEB) , ... September 25, 2017 , ... PITTSBURGH...An ... way to update patient charts in hospitals and medical facilities, so he invented the ... access and update patient charts. In doing so, it offers an improved alternative to ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... supporting clinical research, today announces that 30 of its domain experts will ... development lifecycle at upcoming industry conferences and webinars. Drawing on broad and ...
(Date:9/25/2017)... Korea (PRWEB) , ... September 25, 2017 , ... Earlypicker ... looking for a one-stop shop for the hottest Korean cosmetics and fashion trends sweeping ... for a company that’s already well-known for the great offerings that allow Koreans everywhere ...
(Date:9/25/2017)... ... , ... “The Majestic Unicorn”: a poignant book that describes what happened ... creation of published author, Dayna Chantel, an artist and a writer. , Chantel shares, ... aboard the cypress ark-vessel. Male and female, no matter what species, they were chosen ...
(Date:9/25/2017)... ... ... Emerald Ash Borers kill Ash trees in as little as 1-3 years. The ... video by Rob Nagy, ISA Certified Arborist at Giroud Tree and Lawn, shows a street ... showing signs of decline from Emerald Ash Borers, two Ash trees continue to thrive. ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... SAN ANTONIO , Sept. 6, 2017  Robert ... as a Pinnacle Professional Member in recognition of his ... Dr. Szewc serves as a Nephrologist at the practice ... services, emergency medicine, kidney care and hypertension solutions. He ... over 20 years of career experience, as well as ...
(Date:9/6/2017)... Sept. 6, 2017   PDI , a leader in ... host an educational session focused on the role of ... prevention at the 2017 Annual Scientific Meeting of the ... place at the Phoenix Convention ... Sept. 16-19, will also feature PDI,s Prevantics® Device ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
Breaking Medicine Technology: